-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Denosumab for treatment of osteoporosis in postmenopausal women
Ove Torring
Review Article: Clinical Investigation
-
Denosumab for treatment of osteoporosis in postmenopausal women
Ove Torring
Review Article: Clinical Investigation
-
Denosumab for treatment of osteoporosis in postmenopausal women
Ove Torring
Review Article: Clinical Investigation
-
Denosumab for treatment of osteoporosis in postmenopausal women
Ove Torring
Review Article: Clinical Investigation
-
Denosumab for treatment of osteoporosis in postmenopausal women
Ove Torring
Review Article: Clinical Investigation
-
Denosumab for treatment of osteoporosis in postmenopausal women
Ove Torring
Review Article: Clinical Investigation
-
Denosumab for treatment of osteoporosis in postmenopausal women
Ove Torring
Review Article: Clinical Investigation
-
Denosumab for treatment of osteoporosis in postmenopausal women
Ove Torring
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation
-
Fingolimod for the treatment of multiple sclerosis: a review of the evidence from the FREEDOMS and TRANSFORMS studies
Bhupendra O Khatri, John F Kramer
Review Article: Clinical Investigation